CIK 0001802369 · <br>Emerging growth company
ADARx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ADRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 844145188
- Phone
- 858-283-9472
- Business address
- 5871 OBERLIN DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $87,745,772
- in 5 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$87,745,772. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-28 | George Simeon Director | Conversion | +1,667,468 | 1,667,468 | ||
| 2026-09-28 | George Simeon Director | Conversion | +169,001 | 1,836,469 | ||
| 2026-09-28 | George Simeon Director | Purchase | +592,593 | $17.00 | $10.1M | 592,593 |
| 2026-09-28 | George Simeon Director | Conversion · Series B Preferred Stock | −3,907,547 | 0 | ||
| 2026-09-28 | George Simeon Director | Conversion · Series B-1 Preferred Stock | −1,304,883 | 0 | ||
| 2026-09-28 | George Simeon Director | Conversion · Series C Preferred Stock | −600,962 | 0 | ||
| 2026-09-28 | George Simeon Director | Conversion · Series C Preferred Stock | −1,802,885 | 0 | ||
| 2026-09-28 | George Simeon Director | Conversion · Series B Preferred Stock | −1,953,773 | 0 | ||
| 2026-09-28 | George Simeon Director | Conversion · Series B-1 Preferred Stock | −198,019 | 0 | ||
| 2026-09-24 | MacLeod Alan Robert Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +170,692 | 170,692 | ||
| 2026-09-24 | Zhu Rui (NMN) Chief Technology Officer | Grant or award · Employee Stock Option (right to buy) | +512,076 | 512,076 | ||
| 2026-09-24 | Ackles Robert William Chief People Officer | Grant or award · Employee Stock Option (right to buy) | +85,346 | 85,346 | ||
| 2026-09-24 | Fisk Ryan CFO and CBO | Grant or award · Employee Stock Option (right to buy) | +170,692 | 170,692 | ||
| 2026-09-24 | Li Zhen President and CEO | Grant or award · Employee Stock Option (right to buy) | +1,024,152 | 1,024,152 |
Page 5 of 5 · 94 trades